An Integreated R&D Service Company

Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical and medical device outsourcing company with operations in China and the United States.  As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services across the discovery-to-commercialization spectrum. Our services are designed to assist our customers worldwide in shortening the time and lowering the cost of drug and medical device R&D through cost-effective and efficient outsourcing solutions.

WuXi AppTec provides fully integrated pharmaceutical, biotechnology and medical device R&D services to improve the success of research and shorten the time of development by offering our customers world-class capabilities and unparalleled capacities.

We group our operations into two segments:

  • Laboratory Services
    A full range of discovery and development services for pharmaceuticals; development and testing services for biotherapeutics and medical devices; and comprehensive toxicology services. 
  • Manufacturing Services
    Manufacturing services for advanced intermediates and active pharmaceutical ingredients (APIs); cell banking services; and cGMP manufacturing for cellular therapeutics and combination/tissue-based products.

On August 9, 2007, the parent company WuXi PharmaTech (Cayman) Inc. became a New York Stock Exchange listed company and its American Depositary Shares trade under the symbol WX.

Since April 2008, the name of WuXi AppTec's China operations, WuXi PharmaTech Co., Ltd., has been changed to WuXi AppTec Co., Ltd.; and the name of its U.S. operations, AppTec Laboratory Services, Inc., to WuXi AppTec, Inc.